Three Biopharma firms disclosed concerns about how emerging geopolitical tensions between the U.S. and China might impact their business with the contract manufacturer.
The BIOSECURE Act (H.R. 7085), which has the potential to severely restrict the ability of U.S. biopharmaceutical companies to collaborate with certain Chinese entities without losing the ability to contract with the U.S. government, has made headlines in recent weeks.
The Select Committee on the Chinese Communist Party: Gallagher, Krishnamoorthi, colleagues request investigation of all PRC LiDAR technology companies wispolitics.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wispolitics.com Daily Mail and Mail on Sunday newspapers.
With the ever-increasing use of sanctions as a foreign policy tool (or weapon), sanctions compliance has taken on greater importance than ever. Moreover, as countries increase.